Envision Healthcare Corporation (NYSE:EVHC) Cut to Sell at BidaskClub

Bruno Cirelli
Agosto 12, 2017

The business's revenue was up 156.7% compared to the same quarter previous year. BlackRock Inc. now owns 7,345,283 shares of the company's stock valued at $460,330,000 after buying an additional 147,652 shares during the last quarter. Meeder Asset Management Inc.'s holdings in Envision Healthcare were worth $947,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. BB&T Corp raised its position in shares of Envision Healthcare Corporation by 18.2% in the second quarter. Following the completion of the sale, the insider now owns 97,863 shares of the company's stock, valued at $6,135,031.47. WI bought a new stake in Envision Healthcare during the first quarter valued at about $1,881,000. Wellington Management Group LLP increased its position in Envision Healthcare Corporation by 1.2% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company's stock worth $274,000 after buying an additional 240 shares during the last quarter. BlackRock Inc. increased its position in Envision Healthcare Corporation by 2.1% in the second quarter. Douglas Lane & Associates LLC now owns 34,702 shares of the company's stock valued at $2,128,000 after buying an additional 31,289 shares during the period. National Investment Services Inc. Hexavest Inc. bought a new position in Envision Healthcare during the first quarter worth $41,197,000.

Shares of Envision Healthcare Corporation (NYSE EVHC) opened at 52.77 on Tuesday. Envision Healthcare's revenue for the quarter was up 156.7% compared to the same quarter past year. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Envision Healthcare Co. The company's 50-day moving average is $59.52 and its 200-day moving average is $61.20.

Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.75 by $0.04. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company's revenue for the quarter was up 156.7% compared to the same quarter past year. During the same period in the prior year, the firm earned $0.34 EPS. Equities analysts expect that Envision Healthcare Co. will post $1.40 earnings per share for the current fiscal year.

WARNING: This report was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and global copyright & trademark legislation. The correct version of this article can be accessed at https://www.baseball-news-blog.com/2017/08/12/envision-healthcare-co-nyseevhc-sets-new-1-year-low-following-analyst-downgrade.html.

Envision Healthcare Corporation (NYSE:EVHC)'s stock had its "buy" rating restated by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Monday, July 24th. Canaccord Genuity reaffirmed a "buy" rating and set a $86.00 price target on shares of Envision Healthcare Corporation in a research note on Tuesday, April 18th. Finally, BidaskClub upgraded Envision Healthcare Corporation from a sell rating to a hold rating in a research report on Saturday, June 17th. Finally, Royal Bank Of Canada upped their price objective on Envision Healthcare from $72.00 to $77.00 and gave the stock an "outperform" rating in a research note on Tuesday, June 27th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock.

In other news, insider Robert Jon Coward sold 1,500 shares of the business's stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $62.69, for a total transaction of $94,035.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR).

According to the complaint, Envision touted EmCare's capabilities in its public filings, stating, "We believe that EmCare is well-positioned to continue to generate significant organic growth due to its integrated service offerings, differentiated, data-driven processes to recruit and retain physicians, scalable technology and sophisticated risk management programs".

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE